BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8866772)

  • 1. Motor and mental aspects of extrapyramidal syndromes.
    Casey DE
    Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():105-14. PubMed ID: 8866772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute neuroleptic-induced movement disorders.
    Tonda ME; Guthrie SK
    Pharmacotherapy; 1994; 14(5):543-60. PubMed ID: 7997388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition and management of acute neuroleptic-induced extrapyramidal motor and mental syndromes.
    Dose M
    Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():3-13. PubMed ID: 11072761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor and mental aspects of acute extrapyramidal syndromes.
    Casey DE
    Acta Psychiatr Scand Suppl; 1994; 380():14-20. PubMed ID: 7914042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models.
    Casey DE
    Br J Psychiatry Suppl; 1996 May; (29):32-9. PubMed ID: 8733821
    [No Abstract]   [Full Text] [Related]  

  • 8. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE
    Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The continuing problem of extrapyramidal symptoms: strategies for avoidance and effective treatment.
    Gerlach J
    J Clin Psychiatry; 1999; 60 Suppl 23():20-4. PubMed ID: 10625196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extrapyramidal effects of antipsychotic drugs].
    Kulisevsky J; Otermin P
    Neurologia; 2003 Jun; 18(5):262-8. PubMed ID: 12768512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrapyramidal syndromes in nonhuman primates: typical and atypical neuroleptics.
    Casey DE
    Psychopharmacol Bull; 1991; 27(1):47-50. PubMed ID: 1677773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased hexosaminidase activity in antipsychotic-induced extrapyramidal side effects: possible association with higher occurrence in bipolar disorder patients.
    Tunca Z; Resmi H; Ozkara HA; Ciliv G; Celtikci B; Alptekin K; Ozerdem A; Akdede BK; Baykara B; Birsoy B; Ergor G
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1214-20. PubMed ID: 18436361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic aspects of acute extrapyramidal syndromes in nonhuman primates.
    Casey DE
    Psychopharmacol Bull; 1989; 25(3):457-9. PubMed ID: 2516634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The behavioral effects of acute and chronic JL 13, a putative antipsychotic, in Cebus non-human primates.
    Casey DE; Bruhwyler J; Delarge J; Géczy J; Liégeois JF
    Psychopharmacology (Berl); 2001 Sep; 157(3):228-35. PubMed ID: 11605077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia.
    Casey DE
    Schizophr Res; 1991; 4(2):109-20. PubMed ID: 1674881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroleptic induced deficit syndrome].
    Szafrański T
    Psychiatr Pol; 1995; 29(3):359-69. PubMed ID: 7652089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia.
    Kaiser R; Tremblay PB; Klufmöller F; Roots I; Brockmöller J
    Mol Psychiatry; 2002; 7(7):695-705. PubMed ID: 12192613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic treatment and extrapyramidal symptoms amongst schizophrenic inpatients.
    Høiberg MP; Nielsen B
    Nord J Psychiatry; 2006; 60(3):207-12. PubMed ID: 16720511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Extrapyramidal side-effects: avoidance, diagnosis and treatment].
    Fleischhacker WW; Widschwendter C
    Psychiatr Prax; 2005 Apr; 32 Suppl 1():S25-30. PubMed ID: 15818517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.